CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Open-market sale Principal Accounting Officer sold 259 shares at $4.13 ($1,070)
- 4 Planned sale Chief Commercial Officer, MRD sold 16,202 shares at an average $6.62 ($107,318)
- 4 Planned sale Chief Financial Officer sold 134,961 shares at $8.14 ($1,098,583)
- 4 Planned sale Chief Financial Officer sold 70,000 shares at $8.53 ($597,100)
- 4 Open-market sale Chief Financial Officer sold 38,000 shares at $7.16 ($272,080)
- 4 Planned sale Chief Operating Officer sold 3,125 shares at an average $8.60 ($26,863)
- 4 Open-market sale Director sold 2,341 shares at $8.49 ($19,878)
- 4 Grant or award Director acquired 14,775 shares (grant or award)
- 4 Grant or award Director acquired 14,775 shares (grant or award)
- 4 Grant or award Director acquired 14,775 shares (grant or award)
- 4 Grant or award Director acquired 14,775 shares (grant or award)
- 4 Grant or award Director acquired 14,775 shares (grant or award)
- 4 Grant or award Director acquired 14,775 shares (grant or award)
- 4 Grant or award Director acquired 14,775 shares (grant or award)
- 4 Open-market sale Principal Accounting Officer sold 3,529 shares at an average $8.57 ($30,246)
- 4 Open-market sale Chief People Officer sold 6,816 shares at $8.57 ($58,413)
- 4 Open-market sale SVP and General Counsel sold 18,878 shares at an average $8.59 ($162,186)
- 4 Open-market sale Chief Operating Officer sold 23,684 shares at an average $8.59 ($203,487)
- 4 Grant or award Chief Financial Officer acquired 118,203 shares (grant or award)
- 4 Open-market sale Chief Commercial Ofc Imm Med sold 11,749 shares at $8.57 ($100,689)
Page 8 of 28 · 544 filings